Scientific and technological innovation is accelerating the development of effective cancer vaccines, report Drs. Daina Vanags, Cori Gorman and Christian K. Schneider of Biopharma Excellence.
Editor, Rebekah Jordan, sat down with Dr. Gen Li, president and co-founder of Phesi, to learn more about how the company’s AI-driven clinical database is allowing insights and observations to be drawn from big clinical trial data.
Fabio Bertacchini, Senior Director of Product, Proposal and Technical Account Management at Stevanato Group shares how Ready-To-Use vials are answering pharma's call for solutions to aseptic manufacturing challenges.
Christian Merup, CEO of Wellma, explains the winning recipe for successful co-manufacturers in Europe, including the underlying threads and unique capabilities of the leaders in the current CDMO market.
Nick Porter, World Courier, and Chris Williams, Alloga Europe, discuss the heightened demand for cold chain and cryogenic storage to support advanced therapy medicinal products (ATMPs) and the solutions needed to safeguard the supply chain.
A new report published by Connect in Pharma highlights a range of forces shaping the future of the pharmaceutical manufacturing and drug-delivery fields, from machine learning and connected devices to eco-friendly strategies.
Editor, Rebekah Jordan, reviews pharma's transformation to digital solutions, and how the industry will need to navigate the associated risks to prevent breaches in security and safety.
Last Thursday, chancellor Jeremy Hunt announced new measures for smoother medicine approvals in the UK, increased support for R&D, and a simplified tax system for SMEs. UK biotech company, Nevrargenics shared its position on the 2023 Budget.
Editor, Rebekah Jordan, sat with Mark Bagnall, CEO of Phenomix Sciences, to understand how the company is redefining the way obesity disease is treated with precision medicine to allow for better treatment decisions and patient outcomes.
Chris Johnson, managing director at pharmaceutical bearing supplier, SMB Bearings, explains the importance of considered design choices and obsolescence management in pharmaceutical manufacturing.
Bluepharma, a Portuguese pharmaceutical company, has opened an industrial unit specialising in the production of oral solid high-potent drugs, namely in the oncology area.
